$5.80
-0.32-5.23%
al cierre: Nov 20, 4:00 PM EST
$5.80
N/A
After hour: 4:00 PM EST
The average analyst price target for Eupraxia Pharmaceuticals is $16.71, 188.1% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $9 to $25. The latest change came on Nov 11, 2026, when HC Wainwright & Co. raised its price target on Eupraxia Pharmaceuticals from $11 to $16 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
